Status:
COMPLETED
SpotCheck: Comparison of Enhanced Telemedicine Versus In-person Evaluation for the Diagnosis of Skin Cancer
Lead Sponsor:
NYU Langone Health
Conditions:
Skin Cancer
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The overall goal of this research is to develop a platform that can increase patient access to expert skin cancer diagnostic services via telemedicine. This is especially important for medically under...
Detailed Description
This is a prospective pilot study of a store-and-forward telemedicine diagnostic assessment of participant-selected skin lesions concerning for skin cancer, controlled against an in-person dermatologi...
Eligibility Criteria
Inclusion
- Be 18 years of age or older
- Have 1-3 lesions for evaluation
Exclusion
- Lesions of the hair-bearing scalp, in the mouth, on the lips, genitalia, nails, on/around the eyes, inside the ear
Key Trial Info
Start Date :
August 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 4 2023
Estimated Enrollment :
149 Patients enrolled
Trial Details
Trial ID
NCT04411810
Start Date
August 20 2020
End Date
March 4 2023
Last Update
April 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016